Response to venlafaxine in a previously antidepressant treatment-resistant combat veteran with post-traumatic stress disorder

International Clinical Psychopharmacology

Volumn 13, Issue 5, 1998, Pages 233-234

  Hamner, Mark B ^a,b   Frueh, B Christopher ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

Antidepressants; Catecholamines; Post traumatic stress disorder; Serotonin; Venlafaxine

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; HUMAN; MALE; NORADRENERGIC SYSTEM; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; SOLDIER;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CYCLOHEXANOLS; DRUG RESISTANCE; HUMANS; MALE; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS; STRESS DISORDERS, POST-TRAUMATIC; VETERANS;

EID: 0031658746     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199809000-00008     Document Type: Article

References (9)

1. Friedman MJ, Southwick SM (1995). Towards pharmacotherapy for post-traumatic stress disorder. In: Friedman MJ, Charney DS, Deutch AY, editors. Neurobiological and clinical consequences of stress: from normal adaptation to PTSD. Philadelphia: Lippincott-Raven. pp. 465-481.
2. Hamner MB, Diamond OE, Hitri A (1994). Plasma norepinephrine and MHPG responses to exercise stress in PTSD. In: Murburg M, editor. Catecholamine function in posttraumatic stress disorder: emerging concepts. Washington, DC: American Psychiatric Press, Inc. pp. 221-232.
3. Hamner MB, Ulmer H, Horne D (1997). Buspirone potentation of antidepressants in the treatment of PTSD. Depression and Anxiety 5:137-139.
4. Montgomery SA (1993). Venlafaxine: a new dimension in antidepressant pharmacotherapy [academic highlights]. J Clin Psychiatry 54:119-127.
5. McFall ME, Murburg MM (1994). Psychophysiological studies of combat-related PTSD: an integrative review. In: Murburg M, editor. Catecholamine function in post-traumatic stress disorder: emerging concepts. Washington, DC: American Psychiatric Press, Inc. pp. 161-174.
6. Nemeroff CB (1994). Evolutionary trends in the pharmacotherapeutic management of depression. J Clin Psychiatry 55:3-15.
7. Schweizer E, Feighner J, Mandos L, Rickels K (1994). Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients. J Clin Psychiatry 55:104-108.
8. Southwick SM, Krystal JH, Morgan CA, Johnson D, Nagy LM, Nicolaou A, et al. (1993). Abnormal noradrenergic function in posttraumatic stress disorder. Arch Gen Psychiatry 50:266-274.
9. Southwick SM, Yehuda R, Morgan III CA (1995). Clinical studies of neurotransmitter alterations in post-traumatic stress disorder. In: Friedman MJ, Charney DS, Deutch AY, editors. Neurological and clinical consequences of stress: from normal adaptation to PTSD. Philadelphia: Lippencott-Raven, pp. 335-349.